Uptake of new drugs in the early post-approval period in the Mini-Sentinel distributed database-Reference-Cited by-同舟云学术

Uptake of new drugs in the early post-approval period in the Mini-Sentinel distributed database

Published:2016-05-04 Issue:9 Volume:25 Page:1023-1032
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Mott Katrina¹²,Graham David J.¹,Toh Sengwee³,Gagne Joshua J.⁴,Levenson Mark⁵,Ma Yong⁵,Reichman Marsha E.¹

Affiliation:

1. CDER Office of Surveillance and Epidemiology; U.S. Food and Drug Administration; Silver Spring MD USA

2. Department of Epidemiology; Harvard T.H. Chan School of Public Health; Boston MA USA

3. Department of Population Medicine, Harvard Medical School; Harvard Pilgrim Health Care Institute; Boston MA USA

4. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Harvard Medical School; Brigham and Women's Hospital; Boston MA USA

5. CDER Office of Biostatistics; U.S. Food and Drug Administration; Silver Spring MD USA

Funder

U.S. Food and Drug Administration

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference28 articles.

1. Developing the Sentinel System: a national resource for evidence development;Behrman;N Engl J Med,2011

2. The U.S. Food and Drug Administration's Mini-Sentinel Program;Platt;Pharmacoepidemiol Drug Saf,2012

3. Design considerations, architecture, and use of the Mini-Sentinel distributed data system;Curtis;Pharmacoepidemiol Drug Saf,2012

4. Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs;Toh;Pharmacoepidemiol Drug Saf,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Population-level Effect of Adjuvant Therapies on Breast Cancer Recurrence: Application of the Trend-in-Trend Design;Epidemiology;2024-08-06

2. Quantifying the utilization of medical devices necessary to detect postmarket safety differences: A case study of implantable cardioverter defibrillators;Pharmacoepidemiology and Drug Safety;2018-06-12

3. Sequential surveillance for drug safety in a regulatory environment;Pharmacoepidemiology and Drug Safety;2018-03-05

4. The Challenges and Opportunities of Using Large Administrative Claims Databases for Biosimilar Monitoring and Research in the United States;Current Epidemiology Reports;2018-01-26

5. Analytical Approaches for Post-Authorization Safety Studies;Post-Authorization Safety Studies of Medicinal Products;2018